Insider Cluster (2 insiders) ·Filed Apr 17, 2026

TWST

Twist Bioscience Corp
NEUTRAL
Impact 4/10
Horizondays Processed5mo ago
Insider cluster: 2 insiders, $345K total
Actionable Insight • Neutral

The level of insider selling is modest relative to market cap and appears tied to option exercises and personal liquidity planning. Monitor next earnings report for any guidance changes, but no immediate red flags.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
TWST ▲ +54.71% at T+60d
NEUTRAL call ✓ call won +54.71% · α vs SPY +48.56% · entry $59.81 → $92.53
Entry anchored
Apr 16, 03:59 PM ET
via exchange tick
T+1d
+3.46%
call +3.46% · α +3.65%
$61.88
settled 6mo ago
T+5d
+1.89%
call +1.89% · α +1.33%
$60.94
settled 5mo ago
T+20d
-11.47%
call -11.47% · α -16.84%
$52.95
settled 5mo ago
T+60d
+54.71%
call +54.71% · α +48.56%
$92.53
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Twist Bioscience CEO Emily Leproust and CFO Adam Laponis sold a combined $345K in shares over the past week, with the majority of the activity coming from the CFO's $240K open-market sale. The CEO also exercised options and sold a portion of the underlying shares, indicating planned disposition rather than broad insider concern.

Key Financial Metrics

Direction
selling
Total Value
$344.7K
Insiders
2

Key Facts

  • CEO Emily Leproust sold 1,610 shares for $104,666 on 2026-04-21 as part of an option exercise and sale transaction.
  • CFO Adam Laponis sold 4,000 shares for $240,000 on 2026-04-17 in an open-market transaction.
  • Total open-market sales in the cluster amount to $344,666, representing approximately 0.009% of the company's $3.9B market cap.
  • CEO also exercised derivative securities totaling 11,281 shares, with $85,298 in aggregate exercise cost, but no additional open-market sales beyond the 1,610 shares.

Financial Impact

$345K in net insider selling over 7 days

insider ownershipshare count

Risk Factors

  • Concentrated selling by top executives could signal reduced confidence if it continues in future filings.
  • Future option exercises may lead to additional share sales, increasing near-term supply.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)

Investment Themes

Biotech & Drug DiscoveryGenomics & Gene Editing

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-TWST-1776974751453
27 reports for TWST
Performance horizon
88% Hit rate 7 of 8 directional calls best @ T+60▲ +52.11%May 4, 2026
Filters
Rows
Reports for TWST — sortable, filterable
TypeNow
Sep 10, 2026
21d ago
Insider Cluster
NEUTRAL ★ 2/10
$127.22 $166.99▲ +31.26%▲ +31.60%$184.13 (+44.73%)
Aug 27, 2026
5w ago
Insider Cluster
NEUTRAL ★ 4/10
$153.10 $128.71▼ −15.93%▼ −16.20%$184.13 (+20.26%)
Aug 25, 2026
5w ago
Insider Cluster
NEUTRAL ★ 4/10
$151.42 $132.06▼ −12.79%▼ −12.25%$184.13 (+21.60%)
Aug 21, 2026
6w ago
Insider Cluster
NEUTRAL ★ 4/10
$145.59 $141.38▼ −2.89%▼ −3.37%$184.13 (+26.47%)
Aug 20, 2026
6w ago
Insider Cluster
NEUTRAL ★ 3/10
$136.23 $153.10▲ +12.38%▲ +11.27%$184.13 (+35.16%)
Aug 14, 2026
6w ago
Insider Cluster
NEUTRAL ★ 4/10
$124.41 $140.80▲ +13.17%▲ +14.36%$184.13 (+48.00%)
Aug 14, 2026
6w ago
Insider Cluster
BEARISH ★ 6/10
$124.41 $140.80▼ −13.17%▼ −14.36%$184.13 (−48.00%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 4/10
$125.29 $136.23▲ +8.73%▲ +10.70%$184.13 (+46.96%)
Aug 12, 2026
7w ago
144
NEUTRAL ★ 2/10
$125.29 $136.23▲ +8.73%▲ +10.70%$184.13 (+46.96%)
Aug 11, 2026
7w ago
Insider Cluster
NEUTRAL ★ 4/10
$123.12 $116.10▼ −5.70%▼ −5.30%$184.13 (+49.55%)
Showing 10 of 27

US Market Status

Market Open — Closes in 2h 21m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Apr 23, 2026